INDICATIONS & USAGE SECTION Formulated for symptoms associated with vaginal discomfort such as itching, burning, dryness, irritation, soreness and discharge.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Straighten the cleaning solution Pour it into the cleaning position for cleaning Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes,ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
Saline Solution is intended for use in OTC ear,nose,and throat devices intended specifically to administer medicinal substances to treat ear,nose,and throat disorders.These instruments include the powder blower,dropper,ear wick,manual nebulizer pump,and nasal inhaler. If using with an OTC ear,nose,or throat device,the follow the directions provided with the device and only use as directed.
HUIZHOU JINSHENG MEDICAL TECHNOLOGY CO., LTD
FDA
OTC
Usage: This product is designed for gentle cleaning of the face, mouth, nose, eyes, ears, and wounds. It can also be used with a nebulizer to help relieve discomfort in the nose and mouth.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. The pH ranges from 4.5 to 7.0. Composition, osmolarity, and ionic concentration are shown below: 0.9% Sodium Chloride Injection, USP contains 9 g/L Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (calc). It contains 154 mEq/L sodium and 154 mEq/L chloride. The FLEBOFLEX and FLEBOFLEX LUER plastic containers are fabricated from latex-free polyolefins or polypropylene plastic materials. The solution contact materials do not contain PVC, DEHP, or other plasticizers. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. The suitability of the container materials has been established through biological evaluations, which have shown the containers pass Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container systems.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection. 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0). Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water. The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards. The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
0.9% Sodium Chloride Injection, USP solution is sterile and nonpyrogenic. It is a parenteral solution containing sodium chloride in water for injection intended for intravenous administration. For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1,000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solution is a parenteral fluid and electrolyte replenisher. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for injection, USP is chemically designated H2O. The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (freeflex® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
HF ACQUISITION CO LLC, DBA HEALTHFIRST
FDA
Rx Only
Sodium Chloride Injection, USP solutions are sterile and nonpyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. For 0.45% Sodium Chloride Injection, USP, each 100 mL contains 450 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 77 mEq; chloride 77 mEq. The osmolarity is 154 mOsmol/L (calc.). For 0.9% Sodium Chloride Injection, USP, each 100 mL contains 900 mg sodium chloride in water for injection. Electrolytes per 1000 mL: sodium 154 mEq; chloride 154 mEq. The osmolarity is 308 mOsmol/L (calc.). The pH for both concentrations in the 100 mL and smaller containers is 6.0; for the 250 mL and larger containers, the pH is 5.6. The pH range is 4.5 to 7.0 for all containers. The solutions contain no bacteriostat, antimicrobial agent or added buffer and each is intended only as a single-dose injection. When smaller doses are required the unused portion should be discarded. The solutions are parenteral fluid and electrolyte replenishers. Sodium Chloride, USP is chemically designated NaCl, a white crystalline powder freely soluble in water. Water for Injection, USP is chemically designated H2O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.
INDICATIONS: For weight management and inflammation support. This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
3% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, hypertonic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. The pH may have been adjusted with hydrochloric acid. It contains no antimicrobial agents. Composition, ionic concentration, osmolarity, and pH are shown in Table 1 . Table 1. *Normal physiological osmolarity range is approximately 280 to 310 mOsmol/L. Size (mL) Composition (g/L) Ionic Concentration (mEq/L) *Osmolarity (mOsmol/L) (calc) pH Sodium Chloride, USP (NaCl) Sodium Chloride 3% Sodium Chloride Injection, USP 500 30 513 513 1,027 5.0 (4.5 to 7.0) The flexible container is fabricated from a specially formulated non-plasticized, film containing polypropylene and thermoplastic elastomers (free flex ® bag). The amount of water that can permeate from the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the flexible container can leach out certain of the container's chemical components in very small amounts within the expiration period. The suitability of the container material has been confirmed by tests in animals according to USP biological tests for plastic containers.
4 Kids Cold and Cough DaytimeONION CALCIUM SULFIDE SODIUM CHLORIDE PHOSPHORUS PULSATILLA VULGARIS SULFUR AND GOLDENSEAL
Uses* ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
Uses ■ Helps temporarily relieve symptoms of common cold in children at night, including: ■ cough ■ runny nose ■ post nasal drip ■ sneezing ■ sore throat ■ nasal or chest congestion ■ occasional sleeplessness
4 Kids Cold and Mucus NighttimeEUPHRASIA STRICTASILICON DIOXIDE RUMEX CRISPUS ROOT ANEMONE PULSATILLA GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ONION BRYONIA ALBA ROOT MATRICARIA CHAMOMILLA ARABICA COFFEE BEAN CALCIUM SULFIDE AND SULFUR
Uses Temporarily relieves the symptoms of the common cold in children especially at night including accumulation of mucus in chest, throat and nose, cough with mucus, runny nose, sneezing, nasal congestion and occasional sleeplessness.
4 KIDS COLD N COUGH GRAPE FLAVORONION CALCIUM SULFIDE GOLDENSEAL SODIUM CHLORIDE PHOSPHORUS ANEMONE PULSATILLA AND SULFUR
Uses ■Temporarily relieves symptoms of common cold in children, including: ■ accumulation of mucus in chest, throat or nose ■ cough with expectoration of thick, discolored mucus ■ runny nose ■ sneezing ■ nasal or chest congestion
INDICATIONS & USAGE SECTION Bronchitis-Asthma Formulated for symptoms associated with bronchitis, pneumonia, asthma, croup and other respiratory system conditions.
INDICATIONS & USAGE SECTION Hay Fever Formulated for associated symptoms of late Summer and Fall pollens such as itchy eyes, sneezing, post-nasal drip, sore throat and sinus pressure.
INDICATIONS & USAGE SECTION Formulated for associated symptoms such as cramping, alternating constipation & diarrhea, indigestion, bloating and heartburn.
INDICATIONS & USAGE SECTION Gas - Indigestion Formulated for symptoms associated with dyspepsia such as bloating, nausea, eructations and pain or burning sensation in the upper abdomen.
INDICATIONS & USAGE SECTION Hemorrhoids Formulated for symptoms associated with hemorrhoids such as difficult elimination, itching, inflammation, burning pain and pressure.
Influenza Influenzinum (combo), Histaminum hydrochloricum, Aconitum nap., Aralia quinquefolia, Arsenicum alb., Baptisia, Bryonia, Cinchona, Eupatorium perf., Gelsemium, Ipecac., Kali carb., Nux vom., Phosphorus, Rhus toxicodendron, Echinacea ALCOHOL INFLUENZA A VIRUS INFLUENZA A VIRUS INFLUENZA B VIRUS INFLUENZA B VIRUS HISTAMINE DIHYDROCHLORIDE HISTAMINE ACONITUM NAPELLUS ACONITUM NAPELLUS AMERICAN GINSENG AMERICAN GINSENG ARSENIC TRIOXIDE ARSENIC CATION (3+) BAPTISIA TINCTORIA ROOT BAPTISIA TINCTORIA ROOT BRYONIA ALBA ROOT BRYONIA ALBA ROOT CINCHONA OFFICINALIS BARK CINCHONA OFFICINALIS BARK EUPATORIUM PERFOLIATUM FLOWERING TOP EUPATORIUM PERFOLIATUM FLOWERING TOP GELSEMIUM SEMPERVIRENS ROOT GELSEMIUM SEMPERVIRENS ROOT IPECAC IPECAC POTASSIUM CARBONATE CARBONATE ION STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED PHOSPHORUS PHOSPHORUS TOXICODENDRON PUBESCENS LEAF TOXICODENDRON PUBESCENS LEAF ECHINACEA, UNSPECIFIED ECHINACEA, UNSPECIFIED
PRODUCT NAME & INDICATIONS SECTION Influenza Formulated for symptoms associated with colds and flu such as aches, discomfort, fatigue, respiratory dysfunction and digestive upset.
PRODUCT NAME & INDICATIONS SECTION Diabetes Formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger, polyuria, neuralgia and slow-healing wounds.
INDICATIONS & USAGE SECTION Bacterial Infection Formulated for symptoms related to bacterial infections such as fever, chills, fatigue, swollen glands, pain, weakness and loss of appetite.
PRODUCT NAME & INDICATIONS SECTION Gas~Indigestion Formulated for symptoms associated with dyspepsia such as bloating, nausea, eructations and pain or burning sensation in the upper abdomen.
INDICATIONS & USAGE SECTION Diarrhea Formulated for symptoms of intestinal upset such as loose or liquid stools, intestinal cramping, nausea, flatulence and fatigue.
INDICATIONS & USAGE SECTION FEMALE FIBROIDS Formulated for symptoms associated with non-malignant uterine or ovarian fibroids, ovarian or vaginal cysts and uterine polyps.
INDICATIONS & USAGE SECTION Accident - Injury Rescue Formulated for symptoms associated with trauma such as pain, emotional upset, bruising and inflammation.
INDICATIONS & USAGE SECTION Stress~Tension Formulated for associated symptoms such as worry, frustration, emotional sensitivity and the feeling of being mentally and physically drained.
Asthma Rescue - Cough Influenzinum, Antimon. tart., Arsenicum alb., Bryonia, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Histaminum hydrochloricum, Hydrastis, Kali bic., Kali carb., Kali iod., Myrrha, Nat. sulphuricum, Nux vom., Phosphorus, Pulsatilla, Rumex crisp., Sambucus nig., Spongia, Tussilago farfara, Verbascum, Echinacea, Lappa. SODIUM SULFATE SODIUM SULFATE ANHYDROUS STRYCHNOS NUX-VOMICA SEED STRYCHNOS NUX-VOMICA SEED ALCOHOL INFLUENZA A VIRUS INFLUENZA A VIRUS ANTIMONY POTASSIUM TARTRATE ANTIMONY CATION (3+) ARSENIC TRIOXIDE ARSENIC CATION (3+) BRYONIA ALBA ROOT BRYONIA ALBA ROOT CHELIDONIUM MAJUS CHELIDONIUM MAJUS CINCHONA OFFICINALIS BARK CINCHONA OFFICINALIS BARK DROSERA ROTUNDIFOLIA FLOWERING TOP DROSERA ROTUNDIFOLIA FLOWERING TOP EUCALYPTUS GLOBULUS LEAF EUCALYPTUS GLOBULUS LEAF HISTAMINE DIHYDROCHLORIDE HISTAMINE GOLDENSEAL GOLDENSEAL POTASSIUM DICHROMATE DICHROMATE ION POTASSIUM CARBONATE CARBONATE ION POTASSIUM IODIDE IODIDE ION MYRRH MYRRH PHOSPHORUS PHOSPHORUS PULSATILLA VULGARIS PULSATILLA VULGARIS RUMEX CRISPUS ROOT RUMEX CRISPUS ROOT SAMBUCUS NIGRA FLOWERING TOP SAMBUCUS NIGRA FLOWERING TOP SPONGIA OFFICINALIS SKELETON, ROASTED SPONGIA OFFICINALIS SKELETON, ROASTED TUSSILAGO FARFARA TUSSILAGO FARFARA VERBASCUM THAPSUS VERBASCUM THAPSUS ECHINACEA, UNSPECIFIED ECHINACEA, UNSPECIFIED ARCTIUM LAPPA ROOT ARCTIUM LAPPA ROOT INFLUENZA B VIRUS INFLUENZA B VIRUS
INDICATIONS & USAGE SECTION Asthma Rescue - Cough Formulated for symptoms associated with childhood respiratory conditions such as coughing, congestion, labored breathing and wheezing.
INDICATIONS & USAGE SECTION FEMALE FIBROIDS Formulated for symptoms associated with non-malignant uterine or ovarian fibroids, ovarian or vaginal cysts and uterine polyps.
PRODUCT NAME & INDICATIONS SECTION Varicose Veins - Phlebitis Formulated for symptoms associated with varicose veins, phlebitis, ecchymosis, spider veins and other vascular - related conditions.